At SeaStar Medical we recognize that critical care clinicians fight every day to save patients from the cytokine storm. This deadly threat has taken too many organs and too many lives. The severity of this threat is our call to action. We leverage our scientific expertise and resources to break past limitations of current therapies and help our heroes in critical care stop the cytokine storm and save precious lives.
Bring organ-saving, lifesaving solutions to critically ill patients under attack by a cytokine storm
Elevate the standard of care in cell-directed extracorporeal therapy with innovations that transform patient outcomes on a global scale
Professor, Division of Nephrology, Internal Medicine
Center for Integrative Research in Critical Care
University of Michigan
SeaStar Medical is a medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical’s novel technologies provide life-saving solutions to critically ill patients. We are developing and commercializing cell-directed extracorporeal therapies that target the key immune cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
©SeaStar Medical 2023
